






























Fernwood Investment Management LLC Has $770,000 Stake in Caterpillar, Inc. (NYSE:CAT) - Chaffey Breeze













































 
















 



  
 
 
























Daily Ratings & News for Caterpillar Inc.

        
	Complete the form below to receive the latest headlines and analysts' recommendationsfor Caterpillar Inc. with our free daily email newsletter:










Follow @chaffeybreeze












Recent Posts

Country Trust Bank Purchases 39,585 Shares of Procter & Gamble Company (The) (PG)
Welch & Forbes LLC Acquires 3,572 Shares of Facebook, Inc. (FB)
Walt Disney Company (The) (DIS) Position Held by Meyer Handelman Co.
12,712 Shares in 1-800 FLOWERS.COM, Inc. (NASDAQ:FLWS) Acquired by Karp Capital Management Corp
Powell Industries, Inc. (NASDAQ:POWL) Stake Decreased by Ameriprise Financial Inc.
Parametric Portfolio Associates LLC Raises Stake in Party City Holdco Inc. (NYSE:PRTY)
QTS Realty Trust, Inc. (NYSE:QTS) Position Decreased by Parametric Portfolio Associates LLC
American International Group Inc. Has $485,000 Position in Clayton Williams Energy, Inc. (NYSE:CWEI)
Korn/Ferry International (NYSE:KFY) Shares Bought by JPMorgan Chase & Co.
Hamel Associates Inc. Sells 500 Shares of United Parcel Service, Inc. (NYSE:UPS)
WesBanco, Inc. (NASDAQ:WSBC) Stake Reduced by Ameriprise Financial Inc.
Bp Plc Has $6,971,000 Position in Duke Energy Corporation (NYSE:DUK)
JPMorgan Chase & Co. Decreases Position in Chimerix, Inc. (NASDAQ:CMRX)
JPMorgan Chase & Co. Has $2.19 Million Stake in ConnectOne Bancorp, Inc. (NASDAQ:CNOB)
6,155 Shares in Orrstown Financial Services Inc (NASDAQ:ORRF) Acquired by SG Americas Securities LLC
Fernwood Investment Management LLC Has $770,000 Stake in Caterpillar, Inc. (NYSE:CAT)
Schroder Investment Management Group Has $156.11 Million Position in Accenture PLC (NYSE:ACN)
Goldman Sachs Group, Inc. (The) (NYSE:GS) Stake Decreased by NN Investment Partners Holdings N.V.
American International Group Inc. Cuts Position in Shutterstock, Inc. (NYSE:SSTK)
Cibc World Markets Corp Raises Stake in Target Corporation (NYSE:TGT)







Fernwood Investment Management LLC Has $770,000 Stake in Caterpillar, Inc. (NYSE:CAT)


					Posted by Joanna Charbonneau on Jul 23rd, 2017 // No Comments




Fernwood Investment Management LLC lowered its position in  Caterpillar, Inc. (NYSE:CAT) by 8.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor  owned 8,300 shares of the industrial products company’s stock after selling 800 shares during the period. Fernwood Investment Management LLC’s holdings in Caterpillar were worth $770,000 as of its most recent filing with the SEC. 
Several other hedge funds have also recently modified their holdings of CAT. Pacer Advisors Inc. boosted its stake in shares of  Caterpillar by 10.0% in the first quarter. Pacer Advisors Inc. now owns 12,650 shares of the industrial products company’s stock worth $1,173,000 after buying an additional 1,155 shares during the last quarter.  Mason Street Advisors LLC boosted its stake in shares of  Caterpillar by 1.3% in the first quarter. Mason Street Advisors LLC now owns 81,048 shares of the industrial products company’s stock worth $7,518,000 after buying an additional 1,013 shares during the last quarter.  Northstar Wealth Partners LLC purchased a new stake in shares of  Caterpillar during the first quarter worth about $367,000.  Ameritas Investment Partners Inc. boosted its stake in shares of  Caterpillar by 7.2% in the first quarter. Ameritas Investment Partners Inc. now owns 24,282 shares of the industrial products company’s stock worth $2,251,000 after buying an additional 1,630 shares during the last quarter.  Finally, Raymond James Financial Services Advisors Inc. boosted its stake in shares of  Caterpillar by 0.6% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 188,351 shares of the industrial products company’s stock worth $17,471,000 after buying an additional 1,158 shares during the last quarter. Institutional investors and hedge funds own  70.70% of the company’s stock. 


 Get Caterpillar Inc. alerts:



Shares of Caterpillar, Inc. (NYSE:CAT) opened at 106.59 on Friday. The firm’s market capitalization is $62.79 billion. Caterpillar, Inc. has a 52-week low of $78.34 and a 52-week high of $110.00. The company’s 50 day moving average price is $106.32 and its 200 day moving average price is $99.06.  Caterpillar also was the target of unusually large options trading on Thursday. Traders bought  14,052 put options on the stock. This represents an increase of approximately 107% compared to the average daily volume of 6,777 put options.





Caterpillar (NYSE:CAT) last posted its earnings results on Tuesday, April 25th. The industrial products company reported $1.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.62 by $0.66. The business had revenue of $9.82 billion during the quarter, compared to the consensus estimate of $9.27 billion. Caterpillar had a positive return on equity of 16.46% and a negative net margin of 0.38%. Caterpillar’s revenue was up 3.8% on a year-over-year basis. During the same quarter last year, the company earned $0.67 EPS.  Analysts forecast that  Caterpillar, Inc. will post $4.27 earnings per share for the current year. 
The business also recently announced a quarterly dividend, which will be paid on Saturday, August 19th. Investors of record on Thursday, July 20th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 2.93%. The ex-dividend date is Tuesday, July 18th. This is an increase from Caterpillar’s previous quarterly dividend of $0.77. Caterpillar’s dividend payout ratio (DPR) is -1,155.51%. 
TRADEMARK VIOLATION WARNING: “Fernwood Investment Management LLC Has $770,000 Stake in Caterpillar, Inc. (NYSE:CAT)” was first  published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://www.chaffeybreeze.com/2017/07/23/caterpillar-inc-nysecat-stake-reduced-by-fernwood-investment-management-llc-updated.html. 
A number of analysts have recently issued reports on the company. Zacks Investment Research upgraded Caterpillar from a “hold” rating to a “buy” rating and set a $121.00 target price for the company in a report on Friday, July 14th. Axiom Securities  reiterated a “sell” rating on shares of Caterpillar in a report on Thursday, July 13th. Deutsche Bank AG decreased their target price on Caterpillar from $108.00 to $105.00 and set a “buy” rating for the company in a report on Tuesday, July 4th. BidaskClub upgraded Caterpillar from a “hold” rating to a “buy” rating in a report on Saturday, July 1st. Finally, Credit Suisse Group  reiterated a “buy” rating and set a $123.00 target price on shares of Caterpillar in a report on Wednesday, June 28th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned  a hold rating, eleven have assigned  a buy rating and one  has assigned  a strong buy rating to the stock. The stock  has a consensus rating of “Hold” and an average target price of $97.72.
About Caterpillar








Receive News & Ratings for Caterpillar Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caterpillar Inc. and related companies with MarketBeat.com's FREE daily email newsletter.








 






















Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website












 

 















































Fernwood Investment Management, LLC: Private Company Information - Bloomberg









































  





















































































July 28, 2017 3:51 PM ET
Capital Markets

Company Overview of Fernwood Investment Management, LLC



Snapshot People




Company Overview
Fernwood Investment Management, LLC is an investment manager with approximately $96 million in assets under management. The firm provides its services to high net worth individuals. It also manages accounts for charitable organizations, retirement plans, trusts, foundations, and corporations. The firm invests in the public equity and debt markets of the United States. It typically invests in mid-cap and large-cap companies with market capitalizations over $750 million for its equity investments. The firm invests in growth stocks employing a momentum stock picking approach. It buys and holds high quality intermediate and short-term instruments and medium quality intermediate term instruments ...
Fernwood Investment Management, LLC is an investment manager with approximately $96 million in assets under management. The firm provides its services to high net worth individuals. It also manages accounts for charitable organizations, retirement plans, trusts, foundations, and corporations. The firm invests in the public equity and debt markets of the United States. It typically invests in mid-cap and large-cap companies with market capitalizations over $750 million for its equity investments. The firm invests in growth stocks employing a momentum stock picking approach. It buys and holds high quality intermediate and short-term instruments and medium quality intermediate term instruments for its debt investments. Fernwood Investment Management, LLC was founded in 2003 and is based in Quincy, Massachusetts.
Detailed Description


400 Crown Colony DriveSuite 202Quincy, MA 02169United StatesFounded in 2003



Phone: 617-376-4750

Fax: 617-376-4754

www.fernwoodinvestment.com







Key Executives for Fernwood Investment Management, LLC




Mr. Thomas P. Reilly


      	Founder, Managing Member, and Portfolio Manager
      








Ms. Cheryl Smith


      	Director of Client Service
      








Ms. Kristen J. Holland


      	Investment Associate
      





Compensation as of Fiscal Year 2017. 



Similar Private Companies By Industry



Company Name
Region



 @Visory LLC United States 1 Road Partners LLC United States 11T Partners, LLC United States 123Jump.com, Inc. United States 1509225 Ontario, Inc. United States




Recent Private Companies Transactions



TypeDate
Target



No transactions available in the past 12 months.




Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Fernwood Investment Management, LLC, please visit www.fernwoodinvestment.com.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





































Fernwood Investment Management, LLC Buys Global Blood Therapeutics Inc, Ubiquiti Networks Inc, ... - Nasdaq.com

















































































Hot Topics:
ETFs |
Smart Portfolio |
Currencies |
Online Broker Center















Search










































Fernwood Investment Management, LLC Buys Global Blood Therapeutics Inc, Ubiquiti Networks Inc, ...


May 09, 2017, 04:38:03 PM EDT
By insider, GuruFocus









































Shutterstock photo


Fernwood Investment Management, LLCNew Purchases: UBNT , TPL , CLB , OLED, ARRS, EMB, THRM, 4ETA, MNST, TRGP,Added Positions:GBT, JNK, SAGE, CTRP, MO, LUK, FB, JNJ, YUMC, XOM,Reduced Positions:AAPL, ARCC, PTLA, SAFT, BKLN, ALGN, CAT, V, IDU, BIIB,Sold Out:AVGO, ETP, ETP,For the details of Fernwood Investment Management, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Fernwood+Investment+Management%2C+LLCThese are the top 5 holdings of Fernwood Investment Management, LLCGlobal Blood Therapeutics Inc ( GBT ) - 262,510 shares, 7.94% of the total portfolio. Shares added by 356.67%Portola Pharmaceuticals Inc ( PTLA ) - 227,902 shares, 7.33% of the total portfolio. Shares reduced by 5.18%Altria Group Inc ( MO ) - 64,988 shares, 3.81% of the total portfolio. Shares added by 4.17%CVS Health Corp ( CVS ) - 48,223 shares, 3.11% of the total portfolio. Shares reduced by 0.08%iShares U.S. Consumer Goods ( IYK ) - 29,590 shares, 2.88% of the total portfolio. Shares reduced by 0.49%New Purchase: Ubiquiti Networks Inc (UBNT)Fernwood Investment Management, LLC initiated holdings in Ubiquiti Networks Inc. The purchase prices were between $47.94 and $64.13, with an estimated average price of $54.63. The stock is now traded at around $46.84. The impact to the portfolio due to this purchase was 0.83%. The holdings were 20,150 shares as of 2017-03-31.New Purchase: Texas Pacific Land Trust (TPL)Fernwood Investment Management, LLC initiated holdings in Texas Pacific Land Trust. The purchase prices were between $266.59 and $332.6, with an estimated average price of $302.74. The stock is now traded at around $299.55. The impact to the portfolio due to this purchase was 0.34%. The holdings were 1,480 shares as of 2017-03-31.New Purchase: Core Laboratories NV (CLB)Fernwood Investment Management, LLC initiated holdings in Core Laboratories NV. The purchase prices were between $109 and $125.37, with an estimated average price of $116.22. The stock is now traded at around $107.16. The impact to the portfolio due to this purchase was 0.33%. The holdings were 3,505 shares as of 2017-03-31.New Purchase: Universal Display Corp (OLED)Fernwood Investment Management, LLC initiated holdings in Universal Display Corp. The purchase prices were between $57 and $87.3, with an estimated average price of $71.97. The stock is now traded at around $114.30. The impact to the portfolio due to this purchase was 0.33%. The holdings were 4,700 shares as of 2017-03-31.New Purchase: ARRIS International PLC (ARRS)Fernwood Investment Management, LLC initiated holdings in ARRIS International PLC. The purchase prices were between $24.96 and $31.29, with an estimated average price of $27.95. The stock is now traded at around $28.18. The impact to the portfolio due to this purchase was 0.26%. The holdings were 11,800 shares as of 2017-03-31.New Purchase: iShares JP. Morgan USD Emerging Markets Bond (EMB)Fernwood Investment Management, LLC initiated holdings in iShares JP. Morgan USD Emerging Markets Bond. The purchase prices were between $110.22 and $114.06, with an estimated average price of $112.58. The stock is now traded at around $114.07. The impact to the portfolio due to this purchase was 0.26%. The holdings were 2,770 shares as of 2017-03-31.Added: Global Blood Therapeutics Inc ( GBT )Fernwood Investment Management, LLC added to the holdings in Global Blood Therapeutics Inc by 356.67%. The purchase prices were between $14.3 and $39.55, with an estimated average price of $25.19. The stock is now traded at around $28.50. The impact to the portfolio due to this purchase was 6.2%. The holdings were 262,510 shares as of 2017-03-31.Added: SPDR Bloomberg Barclays High Yield Bond (JNK)Fernwood Investment Management, LLC added to the holdings in SPDR Bloomberg Barclays High Yield Bond by 70.12%. The purchase prices were between $36.25 and $37.22, with an estimated average price of $36.79. The stock is now traded at around $36.97. The impact to the portfolio due to this purchase was 0.17%. The holdings were 13,875 shares as of 2017-03-31.Added: Sage Therapeutics Inc (SAGE)Fernwood Investment Management, LLC added to the holdings in Sage Therapeutics Inc by 55.53%. The purchase prices were between $46.01 and $71.07, with an estimated average price of $58.58. The stock is now traded at around $65.32. The impact to the portfolio due to this purchase was 0.17%. The holdings were 8,142 shares as of 2017-03-31.Added: Ctrip.com International Ltd (CTRP)Fernwood Investment Management, LLC added to the holdings in Ctrip.com International Ltd by 37.04%. The purchase prices were between $40.49 and $49.76, with an estimated average price of $45.82. The stock is now traded at around $55.19. The impact to the portfolio due to this purchase was 0.16%. The holdings were 14,800 shares as of 2017-03-31.Sold Out: Broadcom Ltd (AVGO)Fernwood Investment Management, LLC sold out the holdings in Broadcom Ltd. The sale prices were between $174.28 and $226.45, with an estimated average price of $205.92.Sold Out: Energy Transfer Partners LP (ETP)Fernwood Investment Management, LLC sold out the holdings in Energy Transfer Partners LP. The sale prices were between $31.41 and $37.45, with an estimated average price of $34.73.Sold Out: Energy Transfer Partners LP (ETP)Fernwood Investment Management, LLC sold out the holdings in Energy Transfer Partners LP. The sale prices were between $31.41 and $37.45, with an estimated average price of $34.73.Reduced: Safety Insurance Group Inc (SAFT)Fernwood Investment Management, LLC reduced to the holdings in Safety Insurance Group Inc by 40%. The sale prices were between $68.6 and $73.85, with an estimated average price of $71.71. The stock is now traded at around $67.93. The impact to the portfolio due to this sale was -0.22%. Fernwood Investment Management, LLC still held 4,500 shares as of 2017-03-31.Reduced: PowerShares Exchange-Traded Fund Trust (BKLN)Fernwood Investment Management, LLC reduced to the holdings in PowerShares Exchange-Traded Fund Trust by 23.15%. The sale prices were between $23.14 and $23.42, with an estimated average price of $23.31. The stock is now traded at around $23.28. The impact to the portfolio due to this sale was -0.08%. Fernwood Investment Management, LLC still held 11,349 shares as of 2017-03-31.Reduced: General Moly Inc (GMO)Fernwood Investment Management, LLC reduced to the holdings in General Moly Inc by 30.75%. The sale prices were between $0.26 and $0.68, with an estimated average price of $0.48. The stock is now traded at around $0.30. The impact to the portfolio due to this sale was -0.01%. Fernwood Investment Management, LLC still held 63,046 shares as of 2017-03-31.Warning! GuruFocus has detected 1 Warning Sign with GBT. Click here to check it out.GBT 15-Year Financial DataThe intrinsic value of GBTPeter Lynch Chart of GBTPremium MembersThis article first appeared on GuruFocus .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.











This article appears in:
Investing                           
                            
                                , Stocks





Referenced Symbols:

                                        GBT
                                    
, 

                                        PTLA
                                    
, 

                                        MO
                                    
, 

                                        CVS
                                    
, 

                                        IYK
                                    












More from GuruFocus



Subscribe




Warren Buffett: I could make you 50% a year on $1 million
A Strategy Ben Graham Used for 30 Years
Are CEOs Buying?














Related Stocks Articles




Subscribe







Barrick Gold's Q2 2017 Earnings Review: Superior Cost Performance Of Mining Operations Drives Earnings Improvement


						7/28/2017 03:20 PM
					



Ask a Fool: Are There Any Stocks Still Undervalued Now?


						7/28/2017 02:45 PM
					



Intel Corporation Benefiting From the Memory Boom


						7/28/2017 02:45 PM
					














Contributor:GuruFocus
Stock Picks, Portfolios



Follow on:

























Most Popular




Highest Rated








Mitel To Acquire ShoreTel - Quick Facts
Sientra Completes Acquisition of Miramar Labs®
Seagate Technology PLC Q4 Profit Rises 174%
LedgerX gets U.S. approval for derivatives on digital currencies
U.S. Fines Frontier, American And Delta For Violating Consumer







Shareholders Approve Major Structural Change to Top Performing...
Yatra Attains Leadership Position in Corporate Travel With the...
Mitel To Acquire ShoreTel - Quick Facts
Miller Heiman Group Selects CallidusCloud Datahug for Pipeline...
Tractor Supply Company Reports Second Quarter Results




View All Highest Rated






















Research Brokers before you trade



		Compare Online Brokers
	


Want to trade FX?



		Visit our Forex Broker Center 
	
















Find a Credit Card



                    Select a credit card product by:
                


 Card Type
 Credit Score
 Card Issuer



                    Select an offer:
                





0% APR Credit CardsAirline Credit CardsBalance Transfer Credit CardsBusiness Credit CardsCash Back Credit CardsCharge CardsCharge Cards for BusinessEMV Smart ChipsGas Cards & Auto RewardsHome Improvement Rewards Credit CardsInstant Approval Credit CardsLow Interest Credit CardsNo Annual Fee Credit CardsNo Foreign Transaction Fee Credit CardsPoints Rewards Credit CardsPrepaid & Debit CardsReward Credit CardsStudent Credit CardsTop 10 Best Credit Card Deals and Offers




Bad CreditCredit Quality AverageCredit Quality ExcellentCredit Quality FairCredit Quality GoodLimited or No Credit HistoryPersonal Loans




American ExpressAmerican Express Airline CardsAmerican Express Business CardsAmerican Express Cash Back Credit CardsAmerican Express Charge CardsBarclaycardCapital OneCapital One Cash BackCapital One Fair CreditCapital One MilesCapital One PointsCapital One Prepaid Credit CardsChaseCiti Credit CardsDiscoverDiscover CashbackDiscover MilesDiscover Student Credit CardsMasterCard Credit CardsU.S. BankUSAAUSAA SavingsVisa Credit Cards







Search





Data Provided by BankRate.com






Stocks

Referenced





GBT








100%



Rate It





PTLA








100%



Rate It





MO








91%



Rate It





CVS








100%



Rate It





IYK








0%



Rate It































CLOSEX

Edit Favorites

Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.






Update

Clear List







CLOSEX
Customize your NASDAQ.com experience
Background Color Selector

Select the background color of your choice:





 Black
							





 Slate Gray
							






 Light Gray
							





 Gray Blue
							






Quote Search

Select a default target page for your quote search:



						 Real-Time

						 After Hours

						 Pre-Market
 News
					


						 Flash Quote

						 Summary Quote

						 Interactive Charts

						 Default Setting




					Please note that once you make your selection, it will apply to all future visits to NASDAQ.com.
					If, at any time, you are interested in reverting to our default settings, please select Default Setting above.
					
					If you have any questions or encounter any issues in changing your default settings, please email isfeedback@nasdaq.com.
				





CLOSEX
Please confirm your selection:

					You have selected to change your default setting for the Quote Search. This will now be your default target page;
					unless you change your configuration again, or you delete your
					cookies. Are you sure you want to change your settings?


YES
NO













CLOSEX


Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us.





CLOSEX





















































Bing Places for Business
























































































































Bing
 places for business


Sign in using your




Microsoft Account





Work Account





Google Account





Facebook Account

Don't have an account? Create one.





Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft









﻿






























Global Blood Therapeutics, Inc. (GBT) Sees Large Increase in Short Interest - Chaffey Breeze













































 
















 



  
 
 
























Daily Ratings & News for Global Blood Therapeutics Inc.

        
	Complete the form below to receive the latest headlines and analysts' recommendationsfor Global Blood Therapeutics Inc. with our free daily email newsletter:










Follow @chaffeybreeze












Recent Posts

Avnet, Inc. (AVT) Downgraded to Underperform at Bank of America Corporation
BTIG Research Reaffirms “Buy” Rating for Assured Guaranty Ltd. (AGO)
Goldman Sachs Group, Inc. (The) Reiterates €28.00 Price Target for Evonik Industries AG (EVK)
American Assets Trust, Inc. (AAT) Upgraded at Zacks Investment Research
Rotork p.l.c. (ROR) Receives “Buy” Rating from Goldman Sachs Group, Inc. (The)
Zacks: Brokerages Anticipate Federal Signal Corporation (FSS) Will Post Quarterly Sales of $201.90 Million
Capella Education Company (CPLA) CEO J Kevin Gilligan Sells 2,000 Shares of Stock
Facebook, Inc. (FB) VP Colin Stretch Sells 750 Shares of Stock
Steel Dynamics, Inc. (STLD) Insider Christopher A. Graham Sells 5,021 Shares of Stock
Foundation Resource Management Inc. Sells 1,200 Shares of Imperial Oil Ltd (NYSEMKT:IMO)
Bartlett & Co. LLC Sells 10,310 Shares of Cullen/Frost Bankers, Inc. (NYSE:CFR)
Parkland Fuel Corp (TSE:PKI) Plans Monthly Dividend of $0.10
Leap Therapeutics, Inc. (NASDAQ:LPTX) Expected to Post Earnings of -$0.50 Per Share
Skandinaviska Enskilda Banken AB publ Has $1,816,000 Position in Reynolds American Inc (NYSE:RAI)
Fiduciary Trust Co. Lowers Stake in Air Products and Chemicals, Inc. (NYSE:APD)
Lyell Wealth Management LP Decreases Stake in Costco Wholesale Corporation (COST)
Aua Capital Management LLC Maintains Position in Broadcom Limited (AVGO)
Heritage Investors Management Corp Sells 250 Shares of State Street Corporation (NYSE:STT)
State Street Corporation (NYSE:STT) Shares Bought by Atria Investments LLC
ChemoCentryx, Inc. (CCXI) Insider Petrus Bekker Sells 30,000 Shares







Global Blood Therapeutics, Inc. (GBT) Sees Large Increase in Short Interest


					Posted by Charlotte Bryant on Jul 20th, 2017 // No Comments




Global Blood Therapeutics, Inc. (NASDAQ:GBT) was the recipient of a large increase in short interest in June. As of June 30th, there was short interest totalling 5,907,109 shares,  an increase of 48.5% from the June 15th total of 3,976,776 shares. Based on an average trading volume of 1,530,712 shares, the short-interest ratio is currently 3.9 days. Approximately 15.2% of the shares of the company are short sold. 
Global Blood Therapeutics (GBT) opened at 28.05 on Thursday. The stock has a 50 day moving average price of $28.42 and a 200-day moving average price of $27.57. The firm’s market capitalization is $1.22 billion. Global Blood Therapeutics has a one year low of $13.35 and a one year high of $41.15. 


 Get Global Blood Therapeutics Inc. alerts:



Global Blood Therapeutics (NASDAQ:GBT) last posted its quarterly earnings data on Monday, May 1st. The company reported ($0.60) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.71) by $0.11. During the same quarter in the previous year, the business posted ($0.56) earnings per share.  On average, equities analysts forecast that  Global Blood Therapeutics will post ($2.54) earnings per share for the current year. 





Large investors have recently bought and sold shares of the stock. Daiwa SB Investments Ltd. purchased a new stake in  Global Blood Therapeutics during the first quarter valued at approximately $120,000.  Great West Life Assurance Co. Can purchased a new stake in  Global Blood Therapeutics during the first quarter valued at approximately $129,000.  Asset Management One Co. Ltd. purchased a new stake in  Global Blood Therapeutics during the first quarter valued at approximately $130,000.  Legal & General Group Plc raised its stake in  Global Blood Therapeutics by 10.1% in the first quarter. Legal & General Group Plc now owns 4,816 shares of the company’s stock valued at $178,000 after buying an additional 440 shares during the period.  Finally, Raymond James Financial Services Advisors Inc. purchased a new stake in  Global Blood Therapeutics during the first quarter valued at approximately $230,000. Hedge funds and other institutional investors own  71.63% of the company’s stock. 
Several research firms have commented on GBT. BidaskClub cut Global Blood Therapeutics from a “hold” rating to a “sell” rating in a report on Wednesday. SunTrust Banks, Inc. began coverage on Global Blood Therapeutics in a report on Monday, April 17th. They issued a “buy” rating and a $56.00 price target for the company. ValuEngine cut Global Blood Therapeutics from a “hold” rating to a “sell” rating in a report on Saturday, June 3rd. Wedbush  reaffirmed an “outperform” rating and issued a $73.00 price target on shares of Global Blood Therapeutics in a report on Tuesday, May 2nd. Finally, Janney Montgomery Scott began coverage on Global Blood Therapeutics in a report on Monday, May 1st. They issued a “buy” rating and a $37.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, one  has given a hold rating and eleven have assigned  a buy rating to the stock. The company  has an average rating of “Buy” and a consensus price target of $50.37.
WARNING: This report was  posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.chaffeybreeze.com/2017/07/20/global-blood-therapeutics-inc-gbt-sees-large-increase-in-short-interest.html. 
Global Blood Therapeutics Company Profile
Global Blood Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company is developing its initial product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease (SCD).






Receive News & Ratings for Global Blood Therapeutics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Blood Therapeutics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.








 






















Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website












 

 













































Fernwood Investment Management, LLC | Wealthminder











































Fernwood Investment Management, LLC


Fernwood Investment Management, LLC
(CRD# 126144) is a financial advisory firm headquartered in
Quincy, MA.
They
manage $230,964,768 in 479 accounts and
serve the financial needs of clients across 3 states (or territories).




Current Firm Details



Fernwood Investment Management, LLC




400 Crown Colony Drive, Suite 101,
Quincy,
MA
02169
617-376-4750
http://www.fernwoodinvestment.com




http://www.fernwoodinvestment.com







By the Numbers






Total Assets Under Management

231
MILLION



Total Number of Accounts

479
ACCOUNTS



Average Account Value

$482,181







Compensation Options




A percentage of assets under your management






Advisory Services Offered




Portfolio management for individuals and/or small businesses
Portfolio management for pooled investment vehicles (other than investment companies)
Selection of other advisers (including private fund managers)








Types of Clients










Registered States






Registered Investment Advisor


Advisors affiliated with a RIA are permitted to work with up to five clients in nearly-all states* without explicit registration. The map below shows states where this firm has explicit registration only.




CA, FL, MA






Financial Advisors at Fernwood Investment Management, LLC




Showing 1 - 2 of 2 top financial advisors.





1















Kristen J. Holland



CRD#:
5154798



400 Crown Colony Drive, Suite 101,
Quincy,
MA
02169




93

Wealthminder
score








Kristen Holland (CRD# 5154798) is an Investment Advisor Representative working at
Fernwood Investment Management, LLC in Quincy, MA and has 
over 10 years
of experience in the finance industry.






2















Thomas P. Reilly



CRD#:
827625



400 Crown Colony, Suite 101,
Quincy,
MA
02169




83

Wealthminder
score








Thomas Reilly (CRD# 827625) is an Investment Advisor Representative working at
Fernwood Investment Management, LLC in Quincy, MA and has 
over 33 years
of experience in the finance industry.













Our primary data source is public filings of Form ADV as published by the Securities and Exchange Commission (SEC) and made available in accordance with the Freedom of Information Act (FOIA). Supplementary information may be provided by listed advisors or their representatives.
Because many firms provide a variety of products or services, an individual may or may not be registered to operate under all services provided by the firm.Do not rely solely on the information on this page. The information may be inaccurate, incomplete or outdated. For the most accurate and up-to-date information, please search for the firm or individual on the SEC site at
http://www.adviserinfo.sec.gov/IAPD/Content/Search/iapd_Search.aspx







Ready to hire a financial advisor?

Get competitive proposals from multiple advisors.

















Request Proposals























Timeout!



You have been idle and will be logged out in

seconds.


Stay Logged In
Log Out Now














